TearLab Corporation (TEAR)
(Delayed Data from OTC)
$0.06 USD
0.00 (0.00%)
Updated Jul 9, 2020 09:35 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
TearLab Corporation [TEAR]
Reports for Purchase
Showing records 1 - 20 ( 165 total )
Company: TearLab Corporation
Industry: Medical - Instruments
Dropping Coverage due to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
We are dropping coverage of the following stocks
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for TEAR
Provider: ValuEngine, Inc
Company: TearLab Corporation
Industry: Medical - Instruments
Transferring Coverage due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: TearLab Corporation
Industry: Medical - Instruments
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Growth Still Minimal but Improving Metrics - Discovery Encouraging
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
2Q17 Revenue and Earnings Beat; 510(k) Submission Next; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
CE Mark Obtained for TearLab Discovery System; Reiterate Buy and $4 Price Target
Provider: Rodman & Renshaw, Co.
Company: TearLab Corporation
Industry: Medical - Instruments
CE Mark Obtained for TearLab Discovery System; Reiterate Buy and $4 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
2017 1Q Results Reported; Near-Term Revenue Upside Limited; Reducing Price Target to $4
Provider: Rodman & Renshaw, Co.
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
2017 1Q Results Reported; Near-Term Revenue Upside Limited; Reducing Price Target to $4
Provider: H.C. Wainwright & Co., Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
2016 Financial Results; Exploring Strategic Alternatives; Reiterate Buy and Adjusting Price Target to $12
Provider: Rodman & Renshaw, Co.
Company: TearLab Corporation
Industry: Medical - Instruments
No more TEAR? Q4 revenue disappoints, company exploring strategic alternatives
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
4Q Revenue Miss as Growth Continues to Deteriorate; Reiterate Neutral
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
2016 Financial Results; Exploring Strategic Alternatives; Reiterate Buy and Adjusting Price Target to $12
Provider: H.C. Wainwright & Co., Inc.